Nektar Therapeutics
(NKTR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -327,237 | -218,651 | -138,651 | -440,667 | -328,503 |
| Depreciation Amortization | 12,087 | 6,910 | 3,213 | 1,762 | 9,582 |
| Accounts receivable | -6,123 | -10,443 | -5,229 | 6,411 | 2,008 |
| Accounts payable and accrued liabilities | -3,337 | 425 | 2,687 | 12,967 | 16,109 |
| Other Working Capital | 13,789 | -15,275 | 14,703 | 21,688 | 59,555 |
| Other Operating Activity | 96,168 | 75,056 | 45,202 | 69,158 | 37,791 |
| Operating Cash Flow | $-214,653 | $-161,978 | $-78,075 | $-328,681 | $-203,458 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5,504 | -3,594 | -900 | -26,285 | -22,614 |
| Purchase Of Investment | -791,445 | -543,631 | -241,068 | -1,380,865 | -1,028,883 |
| Sale Of Investment | 1,200,422 | 902,030 | 439,735 | 1,614,036 | 1,122,902 |
| Investing Cash Flow | $403,473 | $354,805 | $197,767 | $206,886 | $71,405 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -250,000 | -250,000 | N/A | N/A | N/A |
| Common Stock Issued | 20,651 | 19,120 | 11,077 | 23,355 | 18,449 |
| Financing Cash Flow | $-229,349 | $-230,880 | $11,077 | $23,355 | $18,449 |
| Exchange Rate Effect | 9 | -104 | -97 | -102 | -77 |
| Beginning Cash Position | 96,363 | 96,363 | 96,363 | 194,905 | 194,905 |
| End Cash Position | 55,843 | 58,206 | 227,035 | 96,363 | 81,224 |
| Net Cash Flow | $-40,520 | $-38,157 | $130,672 | $-98,542 | $-113,681 |
| Free Cash Flow | |||||
| Operating Cash Flow | -214,653 | -161,978 | -78,075 | -328,681 | -203,458 |
| Capital Expenditure | -5,504 | -3,594 | -900 | -26,285 | -22,614 |
| Free Cash Flow | -220,157 | -165,572 | -78,975 | -354,966 | -226,072 |